2 Pharma Stocks Soaring on Regulatory Wins

KMPH received two price-target hikes after an FDA nod

Managing Editor
Feb 26, 2018 at 10:29 AM
facebook X logo linkedin


Several pharmaceutical stocks have been making outsized moves in recent weeks. Today, KemPharm Inc (NASDAQ:KMPH) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stocks are in the spotlight, thanks to encouraging regulatory news. At last check, KMPH was trading 3.1% higher at $6.18, after jumping on Friday, and ACHN stock was up 10.5% to trade at $3.27.

Analysts React to KMPH FDA Approval

KemPharm late Friday said the Food and Drug Administration (FDA) approved its opioid painkiller Apadaz for short-term acute pain management. As such, the shares touched an almost two-year high of $7.15 during Friday's trading.

In response, the drug concern received two price-target raises -- to $11 from $7 at Canaccord Genuity, and to $12 from $9 at RBC. However, Cowen and Company cut its price target to $15 from $55.

Covering analysts were optimistic toward the drug stock ahead of the Apadaz news, with all three carrying "strong buy" recommendations. Looking broader, KMPH has had a respectable year on the charts, picking up over 120% in the past six months alone.

ACHN Higher on Positive EMA Panel News

Shares of ACHN are soaring today, after a European Medicines Agency (EMA) panel issued a positive orphan status view for the company's C3G kidney drug, ACH-4471. The penny stock hit a more than three-year low of $2.58 on Feb. 1, but is now pacing for its highest finish since late November, and a second close atop its 80-day moving average -- a feat not accomplished since October.

Short interest on the drugmaker picked up more than 17% over the past two reporting periods, and now represents 6.1% of the stock's total available float. At Achillion Pharma stock's average daily trading volume, it would take about four days for the shorts to cover their bearish bets -- which could translate into a short-covering tailwind.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI